Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Method for synthesizing tafluprost

A technology for tafluprost and compounds, which is applied in the field of synthesizing tafluprost, can solve the problems of low production efficiency, high cost, low purity, etc., and achieve the effect of precise control of reaction conditions and improvement of atom economy

Pending Publication Date: 2021-12-21
上海京河医药科技有限公司
View PDF1 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0005] Aiming at the deficiencies of the prior art, the invention provides a method for synthesizing tafluprost, which solves the problems of high cost, low purity and low production efficiency

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Method for synthesizing tafluprost
  • Method for synthesizing tafluprost
  • Method for synthesizing tafluprost

Examples

Experimental program
Comparison scheme
Effect test

Embodiment

[0038] Such as Figure 1-6 As shown, the embodiment of the present invention provides a method for synthesizing tafluprost, comprising the following specific preparation steps:

[0039] S1. Preliminary reaction, the preliminary medicament is obtained through the oxidation reaction of the original compound, specifically, 9.0g, 1.2eq of NaOCl oxidant, 1.5g, 0.1eq of TEMPO catalyst and 11.7g of NaBr, 1.0eq are added to DCM100mL, stirred for 15 minutes, Cool down to -10-0°C, add 17.2g of the compound of formula 1 in DCM100mL solution dropwise to the above reaction mixture, keep stirring at -10-0°C for 3h, add DCM300mL to dilute, add 10% sodium thiosulfate aqueous solution Perform quenching, keep stirring at 0-10°C for 1 hour, separate the liquids, combine the organic phases, and dry the organic phases with anhydrous sodium sulfate to obtain a preliminary medicament;

[0040] S2. Secondary reaction, the secondary reaction compound is obtained through the Horner-Wadsworth-Emmons re...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention provides a method for synthesizing tafluprost, and relates to the technical field of tafluprost synthesis. The method for synthesizing the tafluprost comprises the following specific preparation steps: S1, primary reaction, S2, secondary reaction, S3, third reaction, S4, fourth reaction, S5, fifth reaction and S6, final reaction. The invention provides the method for synthesizing tafluprost. According to the method for synthesizing tafluprost, racemic Corey lactone diol is used as a raw material, the tafluprost is obtained through oxidation, condensation, fluorination, reduction, recondensation and esterification reaction, the total mass yield of six-step reaction of the preparation method can reach 22%, the process is stable, the prepared tafluprost product is colorless viscous oily liquid, and the purity of the tafluprost product is up to 99% or above.

Description

technical field [0001] The invention relates to the technical field of synthesizing tafluprost, in particular to a method for synthesizing tafluprost. Background technique [0002] Tafluprost is a new prostaglandin analog, mainly used for the treatment of open-angle glaucoma or ocular hypertension in patients with elevated intraocular pressure. The outflow of the sclera reduces intraocular pressure. The 15th hydroxyl group in the traditional prostaglandin analog structure is an essential functional group for prostaglandin receptor agonists to exert physiological activity. Tafluprost replaces this functional group with 2 F atoms, as An isopropyl ester that is rapidly hydrolyzed by corneal esterases to the free acid form, the active form of the compound, tafluprost has about the same affinity for the FP receptors of the iridociliary body as the carboxylic acid product of latanoprost 12 times stronger. [0003] The existing patent (CN103804195B) obtains a universal intermedia...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): C07C69/736C07C67/307
CPCC07C67/307C07C67/00C07D307/935C07C69/736
Inventor 杨君
Owner 上海京河医药科技有限公司
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com